Documentation Hospitals Specialty Pharmacies 
Proxsys Rx
MAY 3, 2023
340B ESP and drug manufacturer restrictions are only part of the reason As we noted in a previous post , for 340B-eligible hospitals dealing with increasingly squeezed bottom lines, an in-house specialty pharmacy offers enormous savings and revenue potential. Novartis is sending a variation of the same letter to hospitals.
Proxsys Rx
APRIL 4, 2024
Why a Specialty Pharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Proxsys Rx
AUGUST 22, 2023
Why a Specialty Pharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Drug Channels
JULY 21, 2020
Last week, I documented that nearly half of U.S. pharmacies now participate in the 340B Drug Pricing Program. Below, we update our exclusive analysis of the biggest specialty pharmacies within 340B. As you will see below, these specialty pharmacies have dramatically increased their participation in the 340B program.
Proxsys Rx
DECEMBER 22, 2023
Why a Specialty Pharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Drug Channels
MARCH 15, 2022
Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more.
Proxsys Rx
AUGUST 28, 2024
According to a report from the advocacy organization 340B Health , “Safety-net hospitals lost $1.1 Again, that’s more than a billion dollars safety net hospitals could have dedicated to serving patients who are often unable to afford healthcare; lost to the restrictions of just five drug companies.
Expert insights. Personalized for you.
52 
Let's personalize your content